Proceedings of the International scientific and practical conference ―Paris Science and Education Forum‖ (March 2-4, 2026) / Publisher website: www.naukainfo.com. – Paris, France, 2026. - 293 p.

274 term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles. Diagnostics (Basel). (2021) 11:2059. doi:10.3390/diagnostics11112059 12. Spera FR, Mistrulli R, Salerno L, Vannini F, Muthukkattil ML, Falcetti R, et al. Post-COVID postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia in the pediatric population. Curr Clin Microbiol Rep. (2024) 11:115–25. doi:10.1007/s40588-024-00217-w 13. Tsampasian V, Bäck M, Bernardi M, Cavarretta E, Debski M, Gati S, et al. Cardiovascular disease as part of long COVID: a systematic review. Eur J Prev Cardiol. (2025) 32:485–98. doi:10.1093/eurjpc/zwae070 14. Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583–90. doi:10.1038/s41591-022-01689-3 15. Coto E, Avanzas P, Gomez J. The renin-angiotensin-aldosterone system and coronavirus disease 2019. Eur Cardiol. (2021) 16:e07. doi:10.15420/ecr.2020.30 16. Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605–2610. doi: 10.1161/CIRCULATIONAHA.104.510461. 17. Ely EW, Brown LM, Fineberg HV, National academies of sciences E, Medicine Committee on Examining the Working Definition for Long C. Long COVID defined. N Engl J Med. (2024) 391:1746–53. doi:10.1056/NEJMsb2408466 18. Shao HH, Yin RX. Pathogenic mechanisms of cardiovascular damage in COVID-19. Mol Med. (2024) 30:92. doi:10.1186/s10020-024-00855-2